Clinical trial
Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer
NCT00313690 · University of Southern California, Other · Withdrawn
Key facts
| NCT number | NCT00313690 |
|---|---|
| Title | Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer |
| Official title | Phase I/II Study of Neoadjuvant Bortezomib in Combination With Docetaxel and Cisplatin Followed by Surgery in Early Stage Non-Small Cell Lung Cancer. |
| Lead sponsor | University of Southern California, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Bortezomib, Docetaxel and Cisplatin |
| Enrollment | 0 |
| Start date | Apr 1, 2006 |
| First posted | Apr 12, 2006 |
| Last update posted | May 21, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: